Quest Diagnostics (DGX) Invested Capital (2009 - 2026)

Quest Diagnostics has disclosed Invested Capital across 18 years of filings, most recently posting $13.5 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 4.12% year-over-year to $13.5 billion; the TTM figure through Jun 2026 stood at $13.5 billion (up 4.12% YoY), while the FY2025 annual figure was $13.4 billion, down 1.84% from the prior year.
• Invested Capital came in at $13.5 billion for Q2 2026 at Quest Diagnostics, up from $13.3 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $13.7 billion in Q3 2024 to a low of $9.9 billion in Q4 2022.
• Average Invested Capital over 5 years is $11.8 billion, with a median of $11.3 billion recorded in 2023.
• Year-over-year, Invested Capital dropped 5.57% in 2022 and gained 27.84% in 2024.
• Over 5 years, Invested Capital stood at $9.9 billion in 2022, then rose by 14.59% to $11.4 billion in 2023, then advanced by 20.02% to $13.6 billion in 2024, then declined by 1.84% to $13.4 billion in 2025, then climbed by 0.67% to $13.5 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $13.5 billion in Q2 2026, $13.3 billion in Q1 2026, and $13.4 billion in Q4 2025.